Reactions of normal and osteoporotic bone to fixation devices

Orthopaedic Issues in Osteoporosis

Volumn , Issue , 2002, Pages 249-268

  Bonucci, Ermanno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4544339595     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (145)

1. Perren, S.M., “Physical and biological aspects of fracture healing with special reference to internal fixation,” Clin. Orthop., 138, 175, 1979.
2. Albrektsson, T., “The reactions of bone to non-cemented implants,” in Bone: Fracture Repair and Regeneration, Hall, B.K., Ed., CRC Press, Boca Raton, FL, 1992, 153.
3. Plenk, H., Jr., “Prosthesis-bone interface,” J. Biomed. Mater. Res., 43, 350, 1998.
4. Perry, C.R., “Bone repair techniques, bone graft, and bone graft substitutes,” Clin. Orthop., 360, 71, 1999.
5. Al-Saffar, N. and Revell, P.A., “Pathology of the bone-implant interfaces,” J. Long-Term Eff. Med. Implants, 9, 319, 1999.
6. Conrad, M.E. and Carpenter, J.T., “Bone marrow necrosis,” Am. J. Hematol., 7, 181, 1979.
7. Lozupone, E., “A quantitative analysis of bone tissue formation in different regions of the spongiosa in the dog skeleton,” Anat. Anz., 145, 425, 1979.
8. Gorski, J.P., “Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms,” Crit. Rev. Oral Biol. Med., 9, 201, 1998.
9. Koch, J.C., “The laws of bone architecture,” Am. J. Anat., 21, 177, 1917.
10. Parfitt, A.M., “Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences,” Calcif. Tissue Int., 36, S123, 1984.
11. Goldstein, S.A., Goulet, R., and McCubbrey, D., “Measurement and significance of three-dimensional architecture to the mechanical integrity of trabecular bone,” Calcif. Tissue Int., 53, S127, 1993.
12. Tenenbaum, H.C., “Cellular origins and theories of differentiation of bone-forming cells,” in Bone: The Osteoblast and Osteocyte, Hall, B.K., Ed., Telford Press, Caldwell, NJ, 1990, 41.
13. Marotti, G., “The structure of bone tissues and the cellular control of their deposition,” It. J. Anat. Embryol., 101, 25, 1996.
14. Bonucci, E., “Basic composition and structure of bone,” in Mechanical Testing of Bone and the Bone-Implant Interface,” An, Y.H. and Draughn, R.A., Eds., CRC Press, Boca Raton, FL, 2000, 3.
15. Hancox, N.M., Biology of Bone, Cambridge University Press, Cambridge, 1972.
16. Chan, Y.L., Alfrey, A.C., Posen, S., et al. “Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology,” Calcif. Tissue Int., 35, 344, 1983.
17. Miller, S.C., Bowman, B.M., Miller, M.A., and Bagi, C.M., “Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats,” Bone, 12, 439, 1991.
18. Yoshida, S., Yamamuro, T., Okumura, H., and Takahashi, H., “Microstructural changes of osteopenic trabeculae in the rat,” Bone, 12, 185, 1991.
19. Ballanti, P., Martelli, A., Mereto, E., and Bonucci, E., “Ovariectomized rats as experimental model of postmenopausal osteoporosis: critical considerations,” It. J. Miner. Electrol. Metab., 7, 243, 1993.
20. Shen, V., Liang, X.G., Birchman, R., et al., “Short term immobilization-induced cancellous bone loss is limited to regions undergoing high turnover and/or modeling in mature rats,” Bone, 21, 71, 1997.
21. Frost, H.M., “Bone ‘mass’ and the ‘mechanostat’: a proposal,” Anat. Rec., 219, 1, 1987.
22. Frost, H.M., “Perspectives: a proposed general model of the ‘mechanostat’ (suggestions from a new skeletal-biologic paradigm),” Anat. Rec., 244, 139, 1996.
23. Frost, H.M., Ferretti, J.L., and Jee, W.S.S., “Perspectives: some role of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research,” Calcif. Tissue Int., 62, 1, 1998.
24. Frost, H.M., “Changing concepts in skeletal physiology: Wolff’s law, the mechanostat, and the ‘Utah paradigm,'" Am. J. Hum. Biol., 10, 599, 1998.
25. Frost, H.M., “From Wolff’s law to the mechanostat: a new ‘face’ of physiology,” J. Orthop. Sci., 3, 282, 1998.
26. Marotti, G., Canè, V., Palazzini, S., and Palumbo, C., “Structure-function relationships in the osteocyte,” It. J. Miner. Electrol. Metab., 4, 93, 1990.
27. Burger, E.H. and Klein-Nulend, J., “Mechanotransduction in bone - role of the lacuno-canalicular network,” FASEB J., 13, S101, 1999.
28. Mikuni-Takagaki, Y., “Mechanical responses and signal transduction pathways in stretched osteocytes,” J. Bone Miner. Metab., 17, 57, 1999.
29. Terai, K., Takano-Yamamoto, T., Ohba, Y., et al., “Role of osteopontin in bone remodeling caused by mechanical stress,” J. Bone Miner. Res., 14, 839, 1999.
30. Raisz, L.G. and Rodan, G.A., “Cellular basis for bone turnover,” in Metabolic Bone Disease and Clinically Related Disorders, 2nd ed., Avioli, L.V. and Krane, S.M., Eds., W. B. Saunders, Philadelphia, 1990, 1.
31. Parfitt, A.M., “Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis,” Calcif. Tissue Int., 28, 1, 1979.
32. Bonucci, E., “The basic multicellular unit of bone,” It. J. Miner. Electrol. Metab., 4, 115, 1990.
33. Baron, R., Vignery, A., and Horowitz, M., “Lymphocytes, macrophages and the regulation of bone remodeling,” in Bone and Mineral Research, Annual 2, Peck, W.A., Ed., Elsevier, Amsterdam, 1984, 175.
34. Burr, D.B. and Martin, R.B., “Errors in bone remodeling: toward a unified theory of metabolic bone disease,” Am. J. Anat., 186, 186, 1989.
35. Huffer, W.E., “Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances,” Lab. Invest., 59, 418, 1988.
36. Carlsson, L., Rostlund, T., Albrektsson, B., et al., “Osseointegration of titanium implants,” Acta Orthop. Scand., 57, 285, 1986.
37. Dhert, W.J.A., Thomsen, P., Blomgren, A.K., et al., “Integration of press-fit implants in cortical bone: a study of interface kinetics,” J. Biomed. Mater. Res., 41, 574, 1998.
38. Ishizaka, M., Tanizawa, T., Sofue, M., et al., “Bone particles disturb new bone formation on the interface of the titanium implant after reaming of the marrow cavity,” Bone, 19, 589, 1996.
39. Ogiso, M., Yamashita, Y., Tabata, T., et al., “The delay method: a new surgical technique for enhancing the bone-binding capability of HAP implants to bone surrounding implant cavity preparations,” J. Biomed. Mater. Res., 28, 805, 1994.
40. Owen, M., “The origin of bone cells in the postnatal organism,” Arthritis Rheumat., 23, 1073, 1980.
41. Rickard, D.J., Kassem, M., Hefferan, T.E., et al., “Isolation and characterization of osteoblast precursor cell from human bone marrow,” J. Bone Miner. Res., 11, 312, 1996.
42. Bruder, S.P., Fink, D.J., and Caplan, A.I., “Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy,” J. Cell. Biochem., 56, 283, 1994.
43. Plenk, H., Jr. and Zitter, H., “Material considerations,” in Endosseous Implants: Scientific and Clinical Aspects, Watzek, G., Ed., Quintessence Books, Berlin, 1996, 63.
44. Hench, L.L., “Biomaterials,” Science, 208, 826, 1980.
45. Hench, L.L. and Wilson, J., “Surface-active biomaterials,” Science, 226, 630, 1984.
46. Raiha, J.E., “Biodegradable implants as intramedullary nails. A survey of recent studies and an introduction to their use,” Clin. Mater., 10, 35, 1992.
47. Hollinger, J.O., Brekke, J., Gruskin, E., and Lee, D., “Role of bone substitutes,” Clin. Orthop., 324, 55, 1996.
48. Simon, J.A., Ricci, J.L., and Di Cesare, P.E., “Bioresorbable fracture fixation in orthopaedics: a comprehensive review. Part I. Basic science and preclinical studies,” Am. J. Orthop., 26, 665, 1997.
49. Daniels, A.U., Chang, M.K., and Andriano, K.P., “Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone,” J. Appl. Biomater., 1, 57, 1990.
50. van der Elst, M., Klein, C.P., de Blieck-Hogervorst, J.M., et al., “Bone tissue response to biodegradable polymers used for intramedullary fracture fixation: a long-term in vivo study in sheep femora,” Biomaterials, 20, 121, 1999.
51. Furukawa, T., Matsusue, Y., Yasunaga, T., et al., “Biodegradation behavior of ultra-high-strength hydroxyapatite/poly (L-lactide) composite rods for internal fixation of bone fractures,” Biomaterials, 21, 889, 2000.
52. Lewandrowski, K.U., Gresser, J.D., Wise, D.L., and Trantol, D.J., “Bioresorbable bone graft substitutes of different osteoconductivities: a histologic evaluation of osteointegration of poly(propylene glycolco-fumaric acid)-based cement implants in rats,” Biomaterials, 21, 757, 2000.
53. Goodman, S., Aspenberg, P., Song, Y., et al., “Polyethylene and titanium alloy particles reduce bone formation. Dose-dependence in bone harvest chamber experiments in rabbits,” Acta Orthop. Scand., 67, 599, 1996.
54. Nawrocki, B., Polette, M., Burlet, H., et al., “Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene,” J. Bone Miner. Res., 14, 288, 1999.
55. Woolf, S.K., An, Y.H., and Friedman, R.J., “Review of methods for evaluating orthopaedic bioabsorbable devices in vivo,” MUSC Orthop. J., 3, 27, 2000.
56. Albrektsson, T. and Hansson, H.A., “An ultrastructural characterization of the interface between bone and sputtered titanium or stainless steel surfaces,” Biomaterials, 7, 201, 1986.
57. Johansson, C.B., Lausmaa, J., Ask, M., et al., “Ultrastructural differences of the interface zone betwen bone and Ti6A14V or commercially pure titanium,” J. Biomed. Eng., 1, 3, 1989.
58. Linder, L., “Osseointegration of metallic implants. I. Light microscopy in the rabbit,” Acta Orthop. Scand., 60, 129, 1989.
59. Linder, L., Obrant, K., and Boivin, G., “Osseointegration of metallic implants. II. Transmission electron microscopy in the rabbit,” Acta Orthop. Scand., 60, 135, 1989.
60. Schmalzried, T.P. and Callaghan, J.J., “Wear in total hip and knee replacements,” J. Bone Joint Surg., 81-A, 115, 1999.
61. Dorr, L.D., Wan, Z., Song, M., and Ranawat, A., “Bilateral total hip arthroplasty comparing hydroxyapatite coating to porous-coated fixation,” J. Arthroplasty, 13, 729, 1998.
62. Simmons, C.A., Valiquette, N., and Pilliar, R.M., “Osseointegration of sintered porous-surfaced and plasma spray-coated implants: an animal model study of early postimplantation healing response and mechanical stability,” J. Biomed. Mater. Res., 47, 127, 1999.
63. Svehla, M., Morberg, P., Zicat, B., et al., “Morphometric and mechanical evaluation of titanium implant integration: comparison of five surface structures,” J. Biomed. Mater. Res., 51, 15, 2000.
64. Soballe, K., Hansen, E.S., Brockstedt-Rasmussen, H., et al., “Gap healing enhanced by hydroxyapatite coating in dogs,” Clin. Orthop., 272, 300, 1991.
65. Goldring, S.R., Schiller, A.L., Roelke, M., et al., “The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis,” J. Bone Joint Surg., 65A, 575, 1983.
66. Willert, H.G., and Puls, P., “Die Reaktion des Knochens auf Knochenzement bei der Allo-Arthroplastik der Hüfte,” Arch. Orthop. Unfall-Chir., 72, 33, 1972.
67. Cornell, C.N. and Lane, J.M., “Current understanding of osteoconduction in bone regeneration,” Clin. Orthop., 355, 267S, 1998.
68. Marini, E., Valdinucci, F., and Bonucci, E., “Bone reconstruction and/or augmentation with hydroxyapatite-fibrin glue: personal experience and review of the literature,” It. J. Miner. Electrol. Metab., 13, 5, 1999.
69. Riley, E.H., Lane, J.M., Urist, M.R., et al., “Bone morphogenetic protein-2. Biology and applications,” Clin. Orthop., 324, 39, 1996.
70. Lind, M., Overgaard, S., Soballe, K., et al., “Transforming growth factor-ß1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs,” J. Orthop. Res., 14, 343, 1996.
71. Linkhart, T.A., Mohan, S., and Baylink, D.J., “Growth factors for bone growth and repair: IGF, TGF-ß and BMP,” Bone, 19, 1S, 1996.
72. Aspenberg, P., Jeppsson, C., Wang, J.S., and Boström, M., “Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: a comparison using bone chambers in rats,” Bone, 19, 499, 1996.
73. Heckman, J.D., Ehler, W., Brooks, B.P., et al., “Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer,” J. Bone Joint Surg., 81A, 1717, 1999.
74. Arnaud, E., Morieux, C., Wybier, M., and De Vernejoul, M.C., “Potentiation of transforming growth factor (TGF-ß1) by natural coral and fibrin in a rabbit cranioplasty model,” Calcif. Tissue Int., 54, 493, 1994.
75. Damien, C.J., Parsons, J.R., Prewett, A.B., et al., “Effect of demineralized bone matrix on bone growth within a porous HA material: a histologic and histometric study,” J. Biomater. Appl., 9, 275, 1995.
76. Gao, T.J., Lindholm, T.S., Kommonen, B., et al., “The use of a coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep,” Int. Orthop., 21, 194, 1997.
77. Koempel, J.A., Patt, B.S., O’Grady, K., et al., “The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone,” J. Biomed. Mater. Res., 41, 359, 1998.
78. Laffargue, Ph., Hildebrand, H.F., Rtaimate, M., et al., “Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits’ bone defects,” Bone, 25, 55S, 1999.
79. Yoshida, K., Bessho, K., Fujimura, K., et al., “Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects,” J. Dent. Res., 78, 1505, 1999.
80. Denissen, H., Montanari, C., Martinetti, R., et al., “Alveolar bone response to submerged bisphosphonate-complexed hydroxyapatite implants,” J. Periodontol., 71, 279, 2000.
81. Kawanabe, K., Okada, Y., Matsusue, Y., et al., “Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic,” J. Bone Joint Surg., 80B, 527, 1998.
82. Ikeda, N., Kawanabe, K., and Nakamura, T., “Quantitative comparison of osteoconduction of porous, dense A-W glass-ceramic and hydroxyapatite granules (effects of granule and pore size),” Biomaterials, 20, 1087, 1999.
83. De Groot, K., Jansen, J.A., Wolke, J.G.C., et al., “Development in bioactive coatings,” in Hydroxyapatite Coating in Orthopaedic Surgery, Geesink, R.G.T. and Manley, M.T., Eds., Raven Press, New York, 1993, 49.
84. McPherson, E.J., Dorr, L.D., Gruen, T.A., and Saberi, M.T., “Hydroxyapatite-coated proximal ingrowth femoral stems. A matched pair control study,” Clin. Orthop., 315, 223, 1995.
85. Yee, A.J., Kreder, H.K., Bookman, I., and Davey, J.R., “A randomized trial of hydroxyapatite coated prostheses in total hip arthroplasty,” Clin. Orthop., 366, 120, 1999.
86. Jaffe, W.L. and Scott, D.F., “Total hip arthroplasty with hydroxyapatite-coated prostheses,” J. Bone Joint Surg., 78A, 1918, 1996.
87. Lemons, J.E., “Ceramics: past, present, and future,” Bone, 19, 121S, 1996.
88. Pazzaglia, U.E., Brossa, F., Zatti, G., et al., “The relevance of hydroxyapatite and spongious titanium coatings in fixation of cementless stems. An experimental comparative study in rat femur employing histologic and microangiographic techniques,” Arch. Orthop. Traumat. Surg., 117, 279, 1998.
89. Oonishi, H., Yamamoto, M., Ishimaru, H., et al., “The effect of hydroxyapatite coating on bone growth into porous titanium alloy implants,” J. Bone Joint Surg., 71B, 213, 1989.
90. Soballe, K., Hansen, E.S., Brockstedt-Rasmussen, H., et al., “Hydroxyapatite coating enhances fixation of porous coated implants. A comparison in dogs between press fit and noninterference fit,” Acta Orthop. Scand., 61, 299, 1990.
91. Tisdel, C.L., Goldberg, V.M., Parr, J.A., et al., “The influence of hydroxyapatite and tricalciumphosphate coating on bone growth into titanium fiber-metal implants,” J. Bone Joint Surg., 76A, 159, 1994.
92. Moroni, A., Toksvig-Larsen, S., Maltarello, M.C., et al., “A comparison of hydroxyapatite-coated, titanium-coated, and uncoated tapered external-fixation pins. An in vivo study in sheep,” J. Bone Joint Surg., 80A, 547, 1998.
93. Lind, M., Overgaard, S., Bunger, C., and Soballe, K., “Improved bone anchorage of hydroxyapatite coated implants compared with tricalcium-phosphate coated implants in trabecular bone in dogs,” Biomaterials, 20, 803, 1999.
94. Bonucci, E., Marini, E., Valdinucci, F., and Fortunato, G., “Osteogenic response to hydroxyapatitefibrin implants in maxillofacial bone defects,” Eur. J. Oral Sci., 105, 557, 1997.
95. Hönig, J.F. and Merten, H.A., “Einfluss punktförmig gelagerter Osteosyntheseplatten in Vergleich zur Konventionellen Osteosyntheseplattenlagerung, auf das subimplantäre Lagerungsgewebe,” Vorläufige Mitt. Unfallchir., 95, 271, 1992.
96. Aspenberg, P. and van der Vis, H., “Fluid pressure may cause periprosthetic osteolysis. Particles are not the only thing,” Acta Orthop. Scand., 69, 1, 1998.
97. Aspenberg, P. and van der Vis, H., “Migration, particles, and fluid pressure. A discussion of causes of prosthetic loosening,” Clin. Orthop., 352, 75, 1998.
98. Skripitz, R. and Aspenberg, P., “Pressure-induced periprosthetic osteolysis: a rat model,” J. Orthop. Res., 18, 481, 2000.
99. Ducheyne, P. and Qiu, Q., “Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function,” Biomaterials, 20, 2287, 1999.
100. Schwartz, Z. and Boyan, B.D., “Underlying mechanisms at the bone-biomaterial interface,” J. Cell. Biochem., 56, 340, 1994.
101. Welsh, R.P., Pilliar, R.M., and Macnab, I., “Surgical implants. The role of surface porosity in fixation to bone and acrylic,” J. Bone Joint Surg., 53A, 963, 1971.
102. Hatano, K., Inoue, H., Kojo, T., et al., “Effect of surface roughness on proliferation and alkaline phosphatase expression of rat calvarial cells cultured on polystyrene,” Bone, 25, 439, 1999.
103. Wassell, D.T., Hall, R.C., and Embery, G., “Adsorption of bovine serum albumin onto hydroxyapatite,” Biomaterials, 16, 697, 1995.
104. Wassell, D.T. and Embery, G., “Adsorption of bovine serum albumin on to titanium powder, " Biomaterials, 17, 859, 1996.
105. Browne, M., Gregson, P.J., and West, R.H., “Characterization of titanium alloy implant surfaces with improved dissolution resistance,” J. Mater. Sci. Mater. Med., 7, 323, 1996.
106. Boyan, B.D., Hummert, T.W., Dean, D.D., and Schwartz, Z., “Role of material surfaces in regulating bone and cartilage cell response,” Biomaterials, 17, 137, 1996.
107. McKee, M.D. and Nanci, A., “Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution, and implications for mineralized tissue formation, turnover, and repair,” Microsc. Res. Technol., 33, 141, 1996.
108. Davies, J.E., “In vitro modeling of the bone/implant interface,” Anat. Rec., 245, 426, 1996.
109. Ayukawa, Y., Takeshita, F., Inoue, T., et al., “An immunoelectron microscopic localization of noncollagenous bone proteins (osteocalcin and osteopontin) at the bone-titanium interface of rat tibiae,” J. Biomed. Mater. Res., 41, 111, 1998.
110. Puleo, D.A. and Nanci, A., “Understanding and controlling the bone-implant interface,” Biomaterials, 20, 2311, 1999.
111. Sinha, R.K. and Tuan, R.S., “Regulation of human osteoblast integrin expression by orthopaedic implant material,” Bone, 18, 451, 1996.
112. Gronowicz, G. and McCarthy, M.B., “Response of human osteoblasts to implant materials: integrinmediated adhesion,” J. Orthop. Res., 14, 878, 1996.
113. Anselme, K., “Osteoblast adhesion on biomaterials,” Biomaterials, 21, 667, 2000.
114. Nanci, A., McCarthy, G.F., Zalzal, S., et al., “Tissue response to titanium implants in the rat tibia: ultrastructural, immunocytochemical and lectin-cytochemical characterization of the bone-titanium interface,” Cells Mater., 4, 1, 1994.
115. Klinger, M.M., Rahemtulla, F., Prince, C.W., et al., “Proteoglycans at the bone-implant interface,” Crit. Rev. Oral Biol. Med., 9, 449, 1998.
116. Marini, E., Valdinucci, F., Silvestrini, G., et al., “Morphological investigations on bone formation in hydroxyapatite-fibrin implants in human maxillary and mandibular bone,” Cells Mater., 4, 231, 1994.
117. Kawaguchi, H., McKee, M.D., Okamoto, H., and Nanci, A., “Immunocytochemical and lectin-gold characterization of the interface between alveolar bone and implanted hydroxyapatite in the rat,” Cells Mater., 3, 337, 1993.
118. Fadda, M., Espa, E., Marceddu, S., and De Santis, E., “I detriti metallici nei fallimenti delle artroprotesi d’anca non cementate. Studio morfologico e ultrastrutturale,” G. Ital. Ortop. Traumat., 22, 119, 1996.
119. Wang, J.Y., Wicklund, B.H., Gustilo, R.B., and Tsukayama, D.T., “Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro,” Biomaterials, 17, 2233, 1996.
120. Shida, J., Trindade, M.C., Goodman, S.B., et al., “Induction of interleukin-6 release in human osteoblast-like cells exposed to titanium particles in vitro,” Calcif. Tissue Int., 67, 151, 2000.
121. Merkel, K.D., Erdmann, J.M., McHugh, F.P., et al., “Tumor necrosis factor-a mediates orthopaedic implant osteolysis,” Am. J. Pathol., 154, 203, 1999.
122. Aspenberg, P. and Herbertsson, P., “Periprosthetic bone resorption. Particles vs. movement,” J. Bone Joint Surg., 78B, 641, 1996.
123. Soballe, K., Brockstedt-Rasmussen, H., Hansen, E.S., and Bünger, C., “Hydroxyapatite coating modifies implant membrane formation. Controlled micromotion studied in dogs,” Acta Orthop. Scand., 63, 128, 1992.
124. Doty, S.B., “Histochemistry and enzymology of osteoclasts,” in Bone: The Osteoclast, Hall, B.K., Ed., CRC Press, Boca Raton, FL, 1991, 61.
125. Bianco, P., Costantini, M., Dearden, L.C., and Bonucci, E., “Expression of tartrate-resistant acid phosphatase in bone marrow macrophages,” Basic Appl. Histochem., 31, 433, 1987.
126. Takagi, M., Santavirta, S., Ida, H., et al., “Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints,” Clin. Prevent. Dent., 352, 35, 1998.
127. Lennox, D.W., Schofield, B.H., McDonald, D.F., and Riley, L.H., “A histologic comparison of aseptic loosening of cemented, press-fit and biologic ingrowth prostheses,” Clin. Orthop., 225, 171, 1987.
128. Faugere, M.C., Friedler, R.M., Fanti, P., and Malluche, H.H., “Bone changes occurring early after cessation of ovarian function in beagle dogs: a histomorphometric study employing sequential biopsies,” J. Bone Miner. Res., 5, 263, 1990.
129. Eriksen, E.F., Hodgson, S.F., Eastell, R., et al., “Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels,” J. Bone Miner. Res., 5, 311, 1990.
130. Bonucci, E., Ballanti, P., Ramires, P.A., et al., “Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin,” Calcif. Tissue Int., 56, 274, 1995.
131. Most, W., van der Wee-Pals, L., Ederveen, A., et al., “Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse,” Bone, 20, 27, 1997.
132. Kleerekoper, M., Villanueva, A.R., Stanciu, J., et al., “The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures,” Calcif. Tissue Int., 37, 594, 1985.
133. Yamazaki, M., Shirota, T., Tokugawa, Y., et al., “Bone reactions to titanium screw implants in ovariectomized animals,” Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 87, 411, 1999.
134. Dorr, L.D., Arnala, I., Faugere, M.C., and Malluche, H.H., “Five-year postoperative results of cemented femoral arthroplasty in patients with systemic bone disease,” Clin. Orthop., 259, 114, 1990.
135. Hara, T., Hayashi, K., Nakashima, K., et al., “The effect of hydroxyapatite coating on the bonding of bone to titanium implants in the femora of ovariectomised rats,” J. Bone Joint Surg., 81B, 705, 1999.
136. McKoy, B.E. and An, Y.H., “An injectable cementing screw for fixation in osteoporotic bone,” J. Biomed. Mater. Res., 53, 216, 2000.
137. Hayashi, K., Uenoyama, K., Mashima, T., and Sugioka, Y., “Remodeling of bone around hydroxyapatite and titanium in experimental osteoporosis,” Biomaterials, 15, 11, 1994.
138. Fini, M., Nicoli Aldini, N., Gandolfi, M.G., et al., “Biomaterials for orthopaedic surgery in osteoporotic bone: a comparative study in osteopenic rats,” Int. J. Artif. Org., 20, 291, 1997.
139. Mori, H., Manabe, M., Kurachi, Y., and Nagumo, M., “Osseointegration of dental implants in rabbit bone with low mineral density,” J. Oral Maxillofac. Surg., 55, 351, 1997.
140. Walsh, W.R., Sherman, P., Howlett, C.R., et al., “Fracture healing in a rat osteopenia model,” Clin. Orthop., 342, 218, 1997.
141. Kubo, T., Shiga, T., Hashimoto, M., et al., “Osteoporosis influences the late period of fracture healing in a rat model prepared by ovariectomy and low calcium diet,” J. Steroid Biochem. Mol. Biol., 68, 197, 1999.
142. Fujimoto, T., Niimi, A., Sawai, T., and Ueda, M., “Effects of steroid-induced osteoporosis on osseointegration of titanium implants,” Int. J. Oral Maxillofac. Impl., 13, 183, 1998.
143. Vignon, G., Meunier, P., Pansu, D., et al., “Enquête clinique et anatomique sur l’étiopathogénie de l’ostéoporose sénile,” Rev. Rhumat., 37, 615, 1970.
144. Hordon, L.D. and Peacock, M., “Osteomalacia and osteoporosis in femoral neck fracture,” Bone Miner., 11, 247, 1990.
145. Ballanti, P. and Bonucci, E., “Histomorphometric aspects of bone in involutive osteoporosis,” G. Ital. Metab. Miner. Elettrol., 2, 203, 1988.